25,508
Views
545
CrossRef citations to date
0
Altmetric
Reviews

The global epidemiology of carbapenemase-producing Enterobacteriaceae

, MD, PhD &
Pages 460-469 | Received 31 May 2016, Accepted 04 Aug 2016, Published online: 05 Sep 2016

References

  • Organization WH. Antimicrobial Resistance: Global Report on Surveillance. 2014; http://wwwwhoint/drugresistance/documents/surveillancereport/en/
  • Centers for Disease Control and Prevention. ANTIBIOTIC RESISTANCE THREATS in the United States, 2013. 2013; http://wwwcdcgov/drugresistance/threat-report-2013/
  • van Duin D, Paterson DL. Multidrug-resistant bacteria in the community: Trends and lessons learned. Infect Dis Clin North Am 2016; 30:377-90; PMID:27208764; https://doi.org/10.1016/j.idc.2016.02.004
  • Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, et al. Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2015; 59:4375-8; PMID:26185273; https://doi.org/10.1128/AAC.00553-15
  • van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 2013; 75:115-20; PMID:23290507; https://doi.org/10.1016/j.diagmicrobio.2012.11.009
  • Van Duin D, Cober E, Richter S, Perez F, Cline M, Kaye K, Kalayjian RC, Salata RA, Evans S, Fowler VG, Jr., et al. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect 2014; 20:O1117-20; PMID:24931918; https://doi.org/10.1111/1469-0691.12714
  • van Duin D, Cober E, Richter S, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA, Kaye KS. Residence in skilled nursing facilities is associated with tigecycline non-susceptibility in carbapenem-resistant klebsiella pneumoniae. Infect Control Hosp Epidemiol 2015; 36(8); 942-8.
  • van Duin D, Doi Y. Outbreak of colistin-resistant, carbapenemase-producing klebsiella pneumoniae: Are we at the end of the road? J Clin Microbiol 2015; 53:3116-7; PMID:26202122; https://doi.org/10.1128/JCM.01399-15
  • Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16:161-8; PMID:26603172; https://doi.org/10.1016/S1473-3099(15)00424-7
  • van Duin D, Bonomo RA. Ceftazidime/avibactam and ceftolozane/tazobactam: “Second generation” beta-Lactam/beta-lactamase combinations. Clin Infect Dis 2016; 63:234-41; PMID:27098166
  • Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-81; PMID:21793988; https://doi.org/10.1111/j.1469-0691.2011.03570.x
  • Centers for Disease Control and Prevention. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) November 2015. Update - CRE Toolkit 2015; www.cdc.gov
  • Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53:3365-70; PMID:19506063; https://doi.org/10.1128/AAC.00126-09
  • Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-96; PMID:23969216; https://doi.org/10.1016/S1473-3099(13)70190-7
  • Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev 2015; 28:565-91; PMID:25926236; https://doi.org/10.1128/CMR.00116-14
  • van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Richter SS, et al. Surveillance of carbapenem-resistant klebsiella pneumoniae: Tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother 2014; 58:4035-41; PMID:24798270; https://doi.org/10.1128/AAC.02636-14
  • Sheppard AE, Stoesser N, Wilson DJ, Sebra R, Kasarskis A, Anson LW, Giess A, Pankhurst LJ, Vaughan A, Grim CJ, et al. Nested russian doll-like genetic mobility drives rapid dissemination of the carbapenem resistance gene blaKPC. Antimicrob Agents Chemother 2016; 60:3767-78; PMID:27067320; https://doi.org/10.1128/AAC.00464-16
  • Tofteland S, Naseer U, Lislevand JH, Sundsfjord A, Samuelsen O. A long-term low-frequency hospital outbreak of KPC-producing Klebsiella pneumoniae involving Intergenus plasmid diffusion and a persisting environmental reservoir. PLoS One 2013; 8:e59015; PMID:23536849; https://doi.org/10.1371/journal.pone.0059015
  • Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8:321-31; PMID:12084099; https://doi.org/10.1046/j.1469-0691.2002.00401.x
  • Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012; 67:1597-606; PMID:22499996; https://doi.org/10.1093/jac/dks121
  • Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45:1151-61; PMID:11257029; https://doi.org/10.1128/AAC.45.4.1151-1161.2001
  • Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE, Jr., Archibald LK, Gaynes RP, Tenover FC. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29:245-52; PMID:10476720; https://doi.org/10.1086/520193
  • Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Ghitan M, Collins B, Bratu S, Quale J. Rise and fall of KPC-producing Klebsiella pneumoniae in New York City. J Antimicrob Chemother 2016; [Epub ahead of print] PMID:27353464; https://doi.org/10.1093/jac/dkw242
  • Centers for Disease Control and Prevention. Tracking CRE. 2016; http://wwwcdcgov/hai/organisms/cre/TrackingCREhtml accessed 5/23/2016
  • Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, et al. Epidemiology of carbapenem-resistant enterobacteriaceae in 7 US communities, 2012-2013. JAMA 2015; 314:1479-87; PMID:26436831; https://doi.org/10.1001/jama.2015.12480
  • Diaz A, Ortiz DC, Trujillo M, Garces C, Jaimes F, Restrepo AV. Clinical characteristics of carbapenem-resistant klebsiella pneumoniae infections in Ill and colonized children in colombia. Pediatr Infect Dis J 2016; 35:237-41; PMID:26569194; https://doi.org/10.1097/INF.0000000000000987
  • Cuzon G, Naas T, Correa A, Quinn JP, Villegas MV, Nordmann P. Dissemination of the KPC-2 carbapenemase in non-Klebsiella pneumoniae enterobacterial isolates from Colombia. Int J Antimicrob Agents 2013; 42:59-62; PMID:23664581; https://doi.org/10.1016/j.ijantimicag.2013.04.002
  • Mojica MF, Correa A, Vargas DA, Maya JJ, Montealegre MC, Rojas LJ, Ruiz SJ, Quinn JP, Villegas MV, Colombian Nosocomial Bacterial Resistance Study G. Molecular correlates of the spread of KPC-producing Enterobacteriaceae in Colombia. Int J Antimicrob Agents 2012; 40:277-9; PMID:22789725; https://doi.org/10.1016/j.ijantimicag.2012.05.006
  • Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD, Kreiswirth BN, Jimenez JN. A two-year surveillance in five colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother 2016; 60:332-42; https://doi.org/10.1128/AAC.01775-15
  • Villegas MV, Pallares CJ, Escandon-Vargas K, Hernandez-Gomez C, Correa A, Alvarez C, Rosso F, Matta L, Luna C, Zurita J, et al. Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing enterobacteriaceae in seven latin american countries. PLoS One 2016; 11:e0154092; PMID:27104910; https://doi.org/10.1371/journal.pone.0154092
  • Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL, European Survey of Carbapenemase-Producing Enterobacteriaceae working g. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 2015; 20(45):pii=30062; PMID:26675038; https://doi.org/10.2807/15607917.ES.2015.20.45.30062
  • Parisi SG, Bartolini A, Santacatterina E, Castellani E, Ghirardo R, Berto A, Franchin E, Menegotto N, De Canale E, Tommasini T, et al. Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014. BMC Infect Dis 2015; 15:244; PMID:26116560; https://doi.org/10.1186/s12879-015-0996-7
  • Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, Losito AR, Bartoletti M, Del Bono V, Corcione S, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 2015; 70:2133-43; PMID:25900159; https://doi.org/10.1093/jac/dkv200
  • Spyropoulou A, Papadimitriou-Olivgeris M, Bartzavali C, Vamvakopoulou S, Marangos M, Spiliopoulou I, Anastassiou ED, Christofidou M. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates. J Med Microbiol 2016; 65:240-6; PMID:26698320; https://doi.org/10.1099/jmm.0.000217
  • Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clin Infect Dis 2014; 58:697-703; PMID:24304707; https://doi.org/10.1093/cid/cit795
  • Lerner A, Solter E, Rachi E, Adler A, Rechnitzer H, Miron D, Krupnick L, Sela S, Aga E, Ziv Y, et al. Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel. Eur J Clin Microbiol Infect Dis 2016; 35:149-54; PMID:26581423; https://doi.org/10.1007/s10096-015-2520-9
  • Zhang F, Zhu D, Xie L, Guo X, Ni Y, Sun J. Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China. Eur J Clin Microbiol Infect Dis 2015; 34:1263-9; PMID:25759112; https://doi.org/10.1007/s10096-015-2356-3
  • Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control 2014; 42:e61-4; PMID:24773806; https://doi.org/10.1016/j.ajic.2014.01.024
  • Chen S, Hu F, Xu X, Liu Y, Wu W, Zhu D, Wang H. High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China. Antimicrob Agents Chemother 2011; 55:2493-4; PMID:21321140; https://doi.org/10.1128/AAC.00047-11
  • Wei DD, Wan LG, Deng Q, Liu Y. Emergence of KPC-producing Klebsiella pneumoniae hypervirulent clone of capsular serotype K1 that belongs to sequence type 11 in Mainland China. Diagn Microbiol Infect Dis 2016; 85:192-4; PMID:27049969; https://doi.org/10.1016/j.diagmicrobio.2015.03.012
  • Kazi M, Drego L, Nikam C, Ajbani K, Soman R, Shetty A, Rodrigues C. Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai. Eur J Clin Microbiol Infect Dis 2015; 34:467-72; PMID:25260787; https://doi.org/10.1007/s10096-014-2249-x
  • Shanmugam P, Meenakshisundaram J, Jayaraman P. blaKPC gene Detection in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae in a Tertiary Care Hospital. J Clin Diagn Res 2013; 7:2736-8; PMID:24551626
  • Mushi MF, Mshana SE, Imirzalioglu C, Bwanga F. Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania. BioMed Res Int 2014; 2014:303104; PMID:24707481; https://doi.org/10.1155/2014/303104
  • Brink AJ, Coetzee J, Clay CG, Sithole S, Richards GA, Poirel L, Nordmann P. Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol 2012; 50:525-7; PMID:22116157; https://doi.org/10.1128/JCM.05956-11
  • Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53:5046-54; PMID:19770275; https://doi.org/10.1128/AAC.00774-09
  • Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597-602; PMID:20705517; https://doi.org/10.1016/S1473-3099(10)70143-2
  • Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11:355-62; PMID:21478057; https://doi.org/10.1016/S1473-3099(11)70059-7
  • Borah VV, Saikia KK, Chandra P, Hazarika NK, Chakravarty R. New Delhi metallo-beta-lactamase and extended spectrum beta-lactamases co-producing isolates are high in community-acquired urinary infections in Assam as detected by a novel multiplex polymerase chain reaction assay. Indian J Med Microbiol 2016; 34:173-82; PMID:27080768; https://doi.org/10.4103/0255-0857.176853
  • Wang S, Zhao SY, Xiao SZ, Gu FF, Liu QZ, Tang J, Guo XK, Ni YX, Han LZ. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China. PLoS One 2016; 11:e0147740; PMID:26824702; https://doi.org/10.1371/journal.pone.0147740
  • Ho PL, Cheung YY, Wang Y, Lo WU, Lai EL, Chow KH, Cheng VC. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong. Eur J Clin Microbiol Infect Dis 2016; 35:379-85; PMID:26740321; https://doi.org/10.1007/s10096-015-2550-3
  • Yao X, Doi Y, Zeng L, Lv L, Liu JH. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis 2016; 16:288-9; PMID:26842777; https://doi.org/10.1016/S1473-3099(16)00057-8
  • Baraniak A, Izdebski R, Fiett J, Gawryszewska I, Bojarska K, Herda M, Literacka E, Zabicka D, Tomczak H, Pewinska N, et al. NDM-producing Enterobacteriaceae in Poland, 2012-14: inter-regional outbreak of Klebsiella pneumoniae ST11 and sporadic cases. J Antimicrob Chemother 2016; 71:85-91; PMID:26386745; https://doi.org/10.1093/jac/dkv282
  • Darley E, Weeks J, Jones L, Daniels V, Wootton M, MacGowan A, Walsh T. NDM-1 polymicrobial infections including Vibrio cholerae. Lancet 2012; 380:1358; PMID:23063285; https://doi.org/10.1016/S0140-6736(12)60911-8
  • Rasheed JK, Kitchel B, Zhu W, Anderson KF, Clark NC, Ferraro MJ, Savard P, Humphries RM, Kallen AJ, `Limbago BM. New Delhi metallo-beta-lactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis 2013; 19:870-8; PMID:23731823; https://doi.org/10.3201/eid1906.121515
  • Centers for Disease C, Prevention. Notes from the field: hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase–Denver, Colorado, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:108; PMID:23407128
  • Centers for Disease C, Prevention. Notes from the Field: New Delhi metallo-beta-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013. MMWR Morb Mortal Wkly Rep 2014; 62:1051; PMID:24381080
  • Kazmierczak KM, Rabine S, Hackel M, McLaughlin RE, Biedenbach DJ, Bouchillon SK, Sahm DF, Bradford PA. Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-beta-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2015; 60:1067-78; PMID:26643349; https://doi.org/10.1128/AAC.02379-15
  • Rozales FP, Ribeiro VB, Magagnin CM, Pagano M, Lutz L, Falci DR, Machado A, Barth AL, Zavascki AP. Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil. Int J Infect Dis 2014; 25:79-81; PMID:24857802; https://doi.org/10.1016/j.ijid.2014.01.005
  • de Araujo CF, Silva DM, Carneiro MT, Ribeiro S, Fontana-Maurell M, Alvarez P, Asensi MD, Zahner V, Carvalho-Assef AP. Detection of Carbapenemase Genes in Aquatic Environments in Rio de Janeiro, Brazil. Antimicrob Agents Chemother 2016; 60:4380-3; PMID:27139469; https://doi.org/10.1128/AAC.02753-15
  • Ktari S, Arlet G, Mnif B, Gautier V, Mahjoubi F, Ben Jmeaa M, Bouaziz M, Hammami A. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother 2006; 50:4198-201; PMID:17015633; https://doi.org/10.1128/AAC.00663-06
  • Chouchani C, Marrakchi R, Henriques I, Correia A. Occurrence of IMP-8, IMP-10, and IMP-13 metallo-beta-lactamases located on class 1 integrons and other extended-spectrum beta-lactamases in bacterial isolates from Tunisian rivers. Scand J Infect Dis 2013; 45:95-103; PMID:22992193; https://doi.org/10.3109/00365548.2012.717712
  • Lowman W, Sriruttan C, Nana T, Bosman N, Duse A, Venturas J, Clay C, Coetzee J. NDM-1 has arrived: first report of a carbapenem resistance mechanism in South Africa. S Afr Med J 2011; 101:873-5; PMID:22273027
  • Rubin JE, Peirano G, Peer AK, Govind CN, Pitout JD. NDM-1-producing Enterobacteriaceae from South Africa: moving towards endemicity? Diagn Microbiol Infect Dis 2014; 79:378-80; PMID:24853768; https://doi.org/10.1016/j.diagmicrobio.2014.04.003
  • de Jager P, Chirwa T, Naidoo S, Perovic O, Thomas J. Nosocomial outbreak of New Delhi metallo-beta-lactamase-1-producing gram-negative bacteria in south africa: A case-control study. PLoS One 2015; 10:e0123337; PMID:25909482; https://doi.org/10.1371/journal.pone.0123337
  • Peirano G, Moolman J, Pitondo-Silva A, Pitout JD. The characteristics of VIM-1-producing Klebsiella pneumoniae from South Africa. Scand J Infect Dis 2012; 44:74-8; PMID:21954935; https://doi.org/10.3109/00365548.2011.614276
  • Poirel L, Benouda A, Hays C, Nordmann P. Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J Antimicrob Chemother 2011; 66:2781-3; PMID:21930570; https://doi.org/10.1093/jac/dkr384
  • Sassi A, Loucif L, Gupta SK, Dekhil M, Chettibi H, Rolain JM. NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob Agents Chemother 2014; 58:5606-8; PMID:24982080; https://doi.org/10.1128/AAC.02818-13
  • Poirel L, Revathi G, Bernabeu S, Nordmann P. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother 2011; 55:934-6; PMID:21115785; https://doi.org/10.1128/AAC.01247-10
  • Dortet L, Poirel L, Anguel N, Nordmann P. New Delhi metallo-beta-lactamase 4-producing Escherichia coli in Cameroon. Emerg Infect Dis 2012; 18:1540-2; PMID:22932298; https://doi.org/10.3201/eid1809.120011
  • Khalifa HO, Soliman AM, Ahmed AM, Shimamoto T, Shimamoto T. NDM-4 and NDM-5-Producing Klebseilla pneumoniae Coinfection in a 6-Month-old Infant. Antimicrob Agents Chemother 2016; 60:4416-7; PMID:27185797
  • Lyman M, Walters M, Lonsway D, Rasheed K, Limbago B, Kallen A. Notes from the field: carbapenem-resistant enterobacteriaceae producing OXA-48-like carbapenemases–United States, 2010-2015. MMWR Morb Mortal Wkly Rep 2015; 64:1315-6; PMID:26633574; https://doi.org/10.15585/mmwr.mm6447a3
  • Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48:15-22; PMID:14693513; https://doi.org/10.1128/AAC.48.1.15-22.2004
  • Baran I, Aksu N. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey. Ann Clin Microbiol Antimicrob 2016; 15:20; PMID:27048322; https://doi.org/10.1186/s12941-016-0136-2
  • Lunha K, Chanawong A, Lulitanond A, Wilailuckana C, Charoensri N, Wonglakorn L, Saenjamla P, Chaimanee P, Angkititrakul S, Chetchotisakd P. High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand. Diagn Microbiol Infect Dis 2016; 85:221-6; PMID:27041106
  • Adler A, Hussein O, Ben-David D, Masarwa S, Navon-Venezia S, Schwaber MJ, Carmeli Y. Post-Acute-Care Hospital Carbapenem-Resistant Enterobacteriaceae Working G. Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13. J Antimicrob Chemother 2015; 70:89-92; PMID:25204343; https://doi.org/10.1093/jac/dku333
  • Ahn C, Butt AA, Rivera JI, Yaqoob M, Hag S, Khalil A, Pitout M, Doi Y. OXA-48-producing Enterobacteriaceae causing bacteremia, United Arab Emirates. Int J Infect Dis 2015; 30:36-7; PMID:25462183; https://doi.org/10.1016/j.ijid.2014.11.008
  • Hammoudi D, Ayoub Moubareck C, Aires J, Adaime A, Barakat A, Fayad N, Hakime N, Houmani M, Itani T, Najjar Z, et al. Countrywide spread of OXA-48 carbapenemase in Lebanon: surveillance and genetic characterization of carbapenem-non-susceptible Enterobacteriaceae in 10 hospitals over a one-year period. Int J Infect Dis 2014; 29:139-44; PMID:25449248; https://doi.org/10.1016/j.ijid.2014.07.017
  • Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P. Occurrence of OXA-48 and VIM-1 carbapenemase-producing Enterobacteriaceae in Egypt. Int J Antimicrob Agents 2013; 41:90-1; PMID:23040010; https://doi.org/10.1016/j.ijantimicag.2012.08.015
  • Lafeuille E, Decre D, Mahjoub-Messai F, Bidet P, Arlet G, Bingen E. OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients. Microbial drug resistance 2013; 19:491-7; PMID:23808959; https://doi.org/10.1089/mdr.2012.0219
  • Cuzon G, Bentchouala C, Vogel A, Hery M, Lezzar A, Smati F, Dortet L, Naas T. First outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Constantine, Algeria. Int J Antimicrob Agents 2015; 46:725-7; PMID:26453148; https://doi.org/10.1016/j.ijantimicag.2015.08.005
  • Barguigua A, Zerouali K, Katfy K, El Otmani F, Timinouni M, Elmdaghri N. Occurrence of OXA-48 and NDM-1 carbapenemase-producing Klebsiella pneumoniae in a Moroccan university hospital in Casablanca, Morocco. Infect Genet Evol 2015; 31:142-8; PMID:25620375; https://doi.org/10.1016/j.meegid.2015.01.010
  • Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, Hoban D, Bonomo RA. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother 2011; 66:1992-7; PMID:21676902; https://doi.org/10.1093/jac/dkr240
  • Liu Y, Feng Y, Wu W, Xie Y, Wang X, Zhang X, Chen X, Zong Z. First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing. Antimicrob Agents Chemother 2015; 59:5022-5; PMID:26014927; https://doi.org/10.1128/AAC.00442-15
  • Ma L, Wang JT, Wu TL, Siu LK, Chuang YC, Lin JC, Lu MC, Lu PL. Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan. PLoS One 2015; 10:e0139152; PMID:26414183; https://doi.org/10.1371/journal.pone.0139152
  • Fursova NK, Astashkin EI, Knyazeva AI, Kartsev NN, Leonova ES, Ershova ON, Alexandrova IA, Kurdyumova NV, Sazikina SY, Volozhantsev NV, et al. The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia. Ann Clin Microbiol Antimicrob 2015; 14:46; PMID:26526183; https://doi.org/10.1186/s12941-015-0108-y
  • Al-Agamy MH, Shibl AM, Elkhizzi NA, Meunier D, Turton JF, Livermore DM. Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital. Diagn Microbiol Infect Dis 2013; 76:214-6; PMID:23518186; https://doi.org/10.1016/j.diagmicrobio.2013.02.006
  • Poirel L, Castanheira M, Carrer A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P. OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 2011; 55:2546-51; PMID:21422200; https://doi.org/10.1128/AAC.00022-11
  • Pereira PS, Borghi M, de Araujo CF, Aires CA, Oliveira JC, Asensi MD, Carvalho-Assef AP. Clonal dissemination of OXA-370-producing Klebsiella pneumoniae in Rio de Janeiro, Brazil. Antimicrob Agents Chemother 2015; 59:4453-6; PMID:25987619; https://doi.org/10.1128/AAC.04243-14
  • Brink AJ, Coetzee J, Corcoran C, Clay CG, Hari-Makkan D, Jacobson RK, Richards GA, Feldman C, Nutt L, van Greune J, et al. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol 2013; 51:369-72; PMID:23152549; https://doi.org/10.1128/JCM.02234-12
  • Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136:834-44; PMID:12044132; https://doi.org/10.7326/0003-4819-136-11-200206040-00013
  • Dhar S, Martin ET, Lephart PR, McRoberts JP, Chopra T, Burger TT, Tal-Jasper R, Hayakawa K, Ofer-Friedman H, Lazarovitch T, et al. Risk factors and outcomes for carbapenem-resistant klebsiella pneumoniae isolation, stratified by its multilocus sequence typing: ST258 versus non-ST258. Open Forum Infect Dis 2016; 3:ofv213; PMID:26885543; https://doi.org/10.1093/ofid/ofv213
  • Bart Y, Paul M, Eluk O, Geffen Y, Rabino G, Hussein K. Risk factors for recurrence of carbapenem-resistant enterobacteriaceae carriage: case-control study. Infect Control Hosp Epidemiol 2015; 36:936-41; PMID:25869912; https://doi.org/10.1017/ice.2015.82
  • Bhargava A, Hayakawa K, Silverman E, Haider S, Alluri KC, Datla S, Diviti S, Kuchipudi V, Muppavarapu KS, Lephart PR, et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 2014; 35:398-405; PMID:24602945; https://doi.org/10.1086/675614
  • Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 2007; 60:1124-30; PMID:17884829; https://doi.org/10.1093/jac/dkm356
  • Teo J, Cai Y, Tang S, Lee W, Tan TY, Tan TT, Kwa AL. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study. PLoS One 7:e34254; PMID:22461908; https://doi.org/10.1371/journal.pone.0034254
  • Caballero S, Carter R, Ke X, Susac B, Leiner IM, Kim GJ, Miller L, Ling L, Manova K, Pamer EG. Distinct but spatially overlapping intestinal niches for vancomycin-resistant enterococcus faecium and carbapenem-resistant klebsiella pneumoniae. PLoS Pathog 2015; 11:e1005132; PMID:26334306; https://doi.org/10.1371/journal.ppat.1005132
  • van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012; 67:2090-100; PMID:22678728; https://doi.org/10.1093/jac/dks214

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.